Skip to main content
. Author manuscript; available in PMC: 2014 Jun 5.
Published in final edited form as: Cancer Cell. 2011 Jul 12;20(1):53–65. doi: 10.1016/j.ccr.2011.06.009

Table 1.

Inhibition of Human Histone Methyltransferases by EPZ004777

Enzyme IC50 (nM)a Fold Selectivityb
DOT1L 0.4 ± 0.1 1.0
CARM1 >50,000 >100,000
EHMT2 >50,000 >100,000
EZH1c >50,000 >100,000
EZH2c >50,000 >100,000
PRMT1 >50,000 >100,000
PRMT5 521 ± 137 1280
PRMT8 >50,000 >100,000
SETD7 >50,000 >100,000
WHSC1 >50,000 >100,000
a

IC50 is the concentration of compound resulting in 50% inhibition of enzyme activity. ± error represents the 95% confidence interval.

b

Fold selectivity is relative to DOT1L, and is calculated as the ratio of the IC50 for the enzyme under study over the IC50 for DOT1L.

c

Measured in the context of the PRC2 multiprotein complex.